US Patent Issued to Novartis on Nov. 18 for "Quinoline compounds and compositions for inhibiting EZH2" (American, Chinese, Canadian, Singaporean Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,273, issued on Nov. 18, was assigned to Novartis AG (Basel, Switzerland).

"Quinoline compounds and compositions for inhibiting EZH2" was invented by Xuan Dai (Shanghai), Michael Dore (Quebec, Canada), Xiang-Ju Justin Gu (Shanghai), Ling Li (Shanghai), Kun Chin Liu (Shanghai), Sing Yeung Frankie Mak (Cintech IV, Singapore), Yuan Mi (Shanghai), Counde Oyang (Sunnyvale, Calif.), Julien Papillon (Cambridge, Mass.), Wei (Vicky) Qi (Shanghai), Xiaoxia Yan (Shanghai), Zhengtian Yu (Shanghai), Ji Yue (Jeff) Zhang (Shanghai) and Kehao Zhao (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention disclosed herein relates to aza-quinoline co...